SCHEMBL6207329

SCHEMBL6207329

COc1ccccc1OCC(O)CN1C[CH]N(c2ccc3[nH]ncc3c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.49
PRMT5 O14744 1/20 0.46
WDR77 Q9BQA1 1/20 0.46
MAPT P10636 7/20 0.44
LMNA P02545 6/20 0.44
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
TSHR P16473 3/20 0.44
MAPK1 P28482 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
HIF1A Q16665 2/20 0.44
ADRB1 P08588 2/20 0.44
ADRA2A P08913 2/20 0.44
ADRA2B P18089 2/20 0.44
ADRA2C P18825 2/20 0.44
ADRA1A P35348 2/20 0.44
DRD3 P35462 2/20 0.44
HTR2B P41595 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223317 0.80 KCNH2 (0.47) KCNH2PRMT5WDR77MEN1KMT2A
SCHEMBL5226887 0.77 KCNH2 (0.50) KCNH2PRMT5WDR77CYP3A4CYP1A2
SCHEMBL4866569 0.77 CYP3A4 (0.61) KCNH2LMNAMEN1KMT2AALDH1A1
SCHEMBL6205691 0.76 KCNH2 (0.51) KCNH2PRMT5WDR77CYP3A4CYP1A2
SCHEMBL6205195 0.74 KCNH2 (0.43) KCNH2PRMT5WDR77MEN1KMT2A
SCHEMBL5224373 0.73 IDO1 (0.48) KCNH2MAPTLMNAMEN1KMT2A
SCHEMBL2332160 0.73 LMNA (0.73) KCNH2MAPTLMNAMEN1KMT2A
SCHEMBL6184593 0.72 HRH1 (0.46) KCNH2MAPTLMNAMEN1KMT2A
SCHEMBL5222885 0.71 MEN1 (0.49) KCNH2MAPTLMNAMEN1KMT2A
SCHEMBL31510220 0.69 HRH4 (0.54) KCNH2MAPTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567525-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2005-08-31 EP disclosed
WO-2004052887-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2004-06-24 WO disclosed